Frontiers in Immunology | Multiple Sclerosis and Neuroimmunology

Original Research

Accepted on 06 Feb 2025

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study

in Multiple Sclerosis and Neuroimmunology

Jeske van Pamelen
Carla Rodriguez-Mogeda
Lynn van Olst
Susanne MA van der Pol
Maarten L Boon
Janet De Beukelaar
Oliver HH Gerlach
Andries E Budding
Joep Killestein
Helga E De Vries

Frontiers in Immunology

doi 10.3389/fimmu.2025.1514762

Review

Accepted on 06 Feb 2025

Unraveling the Immune System's Role in Peripheral Nerve Regeneration: A Pathway to Enhanced Healing

in Multiple Sclerosis and Neuroimmunology

Xu Zhang
Yanxian Zhang
Yuqing Chen
Yuxiang Ji
Yongmei Lyu
Zengli Miao
Xuchu Duan
Xiaoyu Liu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540199

Case Report

Published on 06 Feb 2025

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

David Qixiang Chen
José Adalberto Inzunza Domínguez
Juan Manuel Valle Uzeta
Abhiram P. Pushparaj
Jonathan E. Dickinson

Frontiers in Immunology

doi 10.3389/fimmu.2025.1535782

1,620 views

Original Research

Published on 06 Feb 2025

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers

in Multiple Sclerosis and Neuroimmunology

Xin Wang
Ruibin Zhao
Jiayu Fan
Chong Liu
Li Zhang
Huafang Yang
Weiyi Wang

Frontiers in Immunology

doi 10.3389/fimmu.2025.1534172

122 views

Original Research

Accepted on 05 Feb 2025

The changes of NLRs family members in the brain of AD mouse model and AD patients

in Multiple Sclerosis and Neuroimmunology

Zehan Li
Yanling He
Jingdan Zhang
Jing Yang
Jinbo Cheng
Zhang Xuewu

Frontiers in Immunology

doi 10.3389/fimmu.2025.1555124

Case Report

Accepted on 05 Feb 2025

Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes

in Multiple Sclerosis and Neuroimmunology

Masayuki Tahara
Tomonari Awaya
Keisuke Saito
Hideyuki Sawada

Frontiers in Immunology

doi 10.3389/fimmu.2025.1551379

Original Research

Published on 05 Feb 2025

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration

in Multiple Sclerosis and Neuroimmunology

Lucas Stürzbecher
Hendrik Bartolomaeus
Theda U. P. Bartolomaeus
Sylvia Bolz
Andjela Sekulic
Marius Ueffing
Simon J. Clark
Nadine Reichhart
Sergio Crespo-Garcia
Nicola Wilck

Frontiers in Immunology

doi 10.3389/fimmu.2025.1520188

323 views

Original Research

Accepted on 03 Feb 2025

Super-resolution of nodal and paranodal disruption in anti-panneurofascin-associated autoimmune nodopathy

in Multiple Sclerosis and Neuroimmunology

Vinicius Da Cruz Neris Geßner
Janis Theobald Linke
Thomas-Otavio Peulen
Luise Appeltshauser
Claudia Sommer
Dirk Brämer
Christian Geis
Katrin Gertrud Heinze
Kathrin Doppler

Frontiers in Immunology

doi 10.3389/fimmu.2025.1540859

Case Report

Accepted on 03 Feb 2025

MOGAD -a steroid-responsive autoimmune meningoencephalitis mimicking infection

in Multiple Sclerosis and Neuroimmunology

Yihui Goh
Priscillia Pei Shi Lye
Paul Ananth Tambyah
Derek Tuck Loong Soon
Nares Smitasin
Jonathan Ong
Clement Hsiang Rong Yong
Yee Cheun Chan
David Tang
Kay Wei Ping Ng

Frontiers in Immunology

doi 10.3389/fimmu.2025.1516178

301 views

Original Research

Published on 03 Feb 2025

Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering

in Multiple Sclerosis and Neuroimmunology

Ryohei Yamamura
Makoto Kinoshita
Yoshiaki Yasumizu
Tomohiro Yata
Keigo Kihara
Daisuke Motooka
Naoyuki Shiraishi
Yasuko Sugiyama
Shohei Beppu
Hisashi Murata

Frontiers in Immunology

doi 10.3389/fimmu.2025.1508977

238 views

Original Research

Published on 03 Feb 2025

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

in Multiple Sclerosis and Neuroimmunology

Heinz Wiendl
Frederik Barkhof
Xavier Montalban
Anat Achiron
Tobias Derfuss
Andrew Chan
Suzanne Hodgkinson
Alexandre Prat
Letizia Leocani
Klaus Schmierer

Frontiers in Immunology

doi 10.3389/fimmu.2025.1512189

581 views

Case Report

Accepted on 31 Jan 2025

Case report: Plasma exchange as a therapy for Miller-Fisher syndrome

in Multiple Sclerosis and Neuroimmunology

Dongmei Guan
Yuanzhuang SHAN
Hailin ZHANG

Frontiers in Immunology

doi 10.3389/fimmu.2025.1460034

Case Report

Published on 31 Jan 2025

When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report

in Multiple Sclerosis and Neuroimmunology

Palash Kotak
Kashish Khurana
Sarang Raut
Saket Satyasham Toshniwal
Sourya Acharya

Frontiers in Immunology

doi 10.3389/fimmu.2025.1504967

206 views

Original Research

Published on 31 Jan 2025

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis

in Multiple Sclerosis and Neuroimmunology

Vinzenz Fleischer
Tobias Brummer
Muthuraman Muthuraman
Falk Steffen
Milena Heldt
Maria Protopapa
Muriel Schraad
Gabriel Gonzalez-Escamilla
Sergiu Groppa
Stefan Bittner

Frontiers in Immunology

doi 10.3389/fimmu.2025.1532660

228 views

Correction

Published on 31 Jan 2025

Corrigendum: Brain-specific increase in leukotriene signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf War Illness

in Multiple Sclerosis and Neuroimmunology

Sahithi Attaluri
Raghavendra Upadhya
Maheedhar Kodali
Leelavathi N. Madhu
Dinesh Upadhya
Bing Shuai
Ashok K. Shetty

Frontiers in Immunology

doi 10.3389/fimmu.2025.1557065

Original Research

Published on 30 Jan 2025

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators

in Multiple Sclerosis and Neuroimmunology

Michael Hecker
Brit Fitzner
Isis Ludwig-Portugall
Friederike Bohne
Edmar Heyland
Juliane Klehmet
Matthias Grothe
Matthias Schwab
Alexander Winkelmann
Stefanie Meister

Frontiers in Immunology

doi 10.3389/fimmu.2025.1531447

279 views

Navigation group

Articles

The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study

Unraveling the Immune System's Role in Peripheral Nerve Regeneration: A Pathway to Enhanced Healing

Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis

Assessing the inflammation in pediatric MOGAD: Significance of CSF HMGB1 and related biomarkers

The changes of NLRs family members in the brain of AD mouse model and AD patients

Long-term suppression of relapses by dimethyl fumarate in a relapsing pediatric patient with myelin oligodendrocyte glycoprotein antibody-associated disease manifesting as acute disseminated encephalomyelitis, unilateral optic neuritis, and seizure episodes

Outer retina micro-inflammation is driven by T cell responses prior to retinal degeneration in early age-related macular degeneration

Super-resolution of nodal and paranodal disruption in anti-panneurofascin-associated autoimmune nodopathy

MOGAD -a steroid-responsive autoimmune meningoencephalitis mimicking infection

Transcriptome signature in the blood of neuromyelitis optica spectrum disorder under steroid tapering

Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study

Case report: Plasma exchange as a therapy for Miller-Fisher syndrome

When thyroid met brain: the enigma of steroid responsive encephalopathy associated with autoimmune thyroiditis a case report

Biomarker combinations from different modalities predict early disability accumulation in multiple sclerosis

Corrigendum: Brain-specific increase in leukotriene signaling accompanies chronic neuroinflammation and cognitive impairment in a model of Gulf War Illness

Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators